Literature DB >> 1474271

Meningococcal disease in Wales: clinical features, outcome and public health management.

S R Palmer1, J Corson, R Hall, S Payne, J Ludlow, B Deere, H Jones, S Kaul, J Stubbins, R Williams.   

Abstract

In Wales, in 1988, 119 patients with meningococcal disease were identified, so giving a crude annual incidence of 4.2 patients per 100,000 population. The combined classical clinical features of fever, vomiting, neck stiffness, headache and purpuric rash were identified in only 9% of patients. Fever and vomiting were the commonest symptoms, both being present in 60% of patients. A rash was noted in 77% of patients but neck stiffness in only 39%. Rash was more common in children, headache and photophobia in adults. A total of 13 patients died, the fatality rare increasing with age from 3% in infants to 20% in older teenagers and adults. Only 15% of 75 patients admitted to hospital by general practitioners were known to have received intravenous or intramuscular penicillin before admission as recommended by the Chief Medical Officers of the Health Departments in the U.K. Only 24% of patients received rifampicin to clear nasopharyngeal carriage before or at discharge from hospital. Altogether, 375 household contacts of patients were identified. At least 84% of them received chemoprophylaxis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1474271     DOI: 10.1016/0163-4453(92)91699-c

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  6 in total

Review 1.  Effectiveness of antibiotics given before admission in reducing mortality from meningococcal disease: systematic review.

Authors:  Susan J M Hahné; André Charlett; Bernadette Purcell; Susanne Samuelsson; Ivonne Camaroni; Ingrid Ehrhard; Sigrid Heuberger; Maria Santamaria; James M Stuart
Journal:  BMJ       Date:  2006-06-03

2.  Meningococcal antibody titres in infants of women immunised with meningococcal polysaccharide vaccine during pregnancy.

Authors:  T J O'Dempsey; T McArdle; S J Ceesay; O Secka; E Demba; W A Banya; N Francis; B M Greenwood
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-01       Impact factor: 5.747

Review 3.  Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Authors:  M van Deuren; P Brandtzaeg; J W van der Meer
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

4.  Mortality from group C meningococcal disease: a case for a conjugate vaccine?

Authors:  F A Riordan; O Marzouk; A P Thomson; J A Sills; C A Hart
Journal:  Eur J Pediatr       Date:  1994-11       Impact factor: 3.183

5.  Patient and strain characteristics in relation to the outcome of meningococcal disease: a multivariate analysis.

Authors:  R J Scholten; H A Bijlmer; H A Valkenburg; J Dankert
Journal:  Epidemiol Infect       Date:  1994-02       Impact factor: 2.451

Review 6.  Recognizing meningococcal disease: the case for further research in primary care.

Authors:  S Granier; P Owen; N C Stott
Journal:  Br J Gen Pract       Date:  1998-04       Impact factor: 5.386

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.